Security key
492327101
Keros Therapeutics, Inc. - Common Stock, $0.0001 par value per share (KROS)
CUSIP: 492327101
Q3 2023 13F Holders as of 30 Sep 2023
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 19,716,217
- Total 13F shares
- 22,915,590
- Share change
- +492,303
- Total reported value
- $730,562,303
- Put/Call ratio
- 0.78%
- Price per share
- $31.88
- Number of holders
- 106
- Value change
- +$10,983,703
- Number of buys
- 51
- Number of sells
- 49
Report period
Q3 2023
Institutions
106
Top holders
10
KROS full security history
Newer quarter: Q4 2023
Previous quarter: Q2 2023
Keros Therapeutics, Inc. SEC filings
Keros Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 492327101
Recent filing periods:
Top shareholders of KROS - Keros Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
21%
|
4,059,041
|
$163,092,266 | — | 30 Jun 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
8.8%
|
1,744,397
|
$70,089,871 | — | 30 Jun 2023 | |
| ALKEON CAPITAL MANAGEMENT LLC |
13F
|
Company |
8.5%
|
1,676,522
|
$67,362,653 | — | 30 Jun 2023 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
7.7%
|
1,514,734
|
$60,862,012 | — | 30 Jun 2023 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
6.4%
|
1,270,361
|
$51,044,000 | — | 30 Jun 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
6%
|
1,183,779
|
$47,564,239 | — | 30 Jun 2023 | |
| BRAIDWELL LP |
13F
|
Company |
5.8%
|
1,143,865
|
$45,960,496 | — | 30 Jun 2023 | |
| STATE STREET CORP |
13F
|
Company |
5.2%
|
1,015,903
|
$40,818,983 | — | 30 Jun 2023 | |
| S.c.a. Candriam |
13F
|
Individual |
3.7%
|
721,061
|
$28,972,231 | — | 30 Jun 2023 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
2.9%
|
580,000
|
$23,304,400 | — | 30 Jun 2023 | |
| Yiheng Capital Management, L.P. |
13F
|
Company |
2.8%
|
554,151
|
$22,265,787 | — | 30 Jun 2023 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
2.5%
|
497,161
|
$19,975,929 | — | 30 Jun 2023 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
2.4%
|
472,751
|
$18,995,136 | — | 30 Jun 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.1%
|
420,722
|
$16,904,609 | — | 30 Jun 2023 | |
| First Light Asset Management, LLC |
13F
|
Company |
2.1%
|
416,830
|
$16,748,229 | — | 30 Jun 2023 | |
| CHI Advisors LLC |
13F
|
Company |
2%
|
402,118
|
$16,157,101 | — | 30 Jun 2023 | |
| Opaleye Management Inc. |
13F
|
Company |
1.8%
|
352,650
|
$14,169,477 | — | 30 Jun 2023 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.8%
|
349,660
|
$14,049,339 | — | 30 Jun 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.7%
|
327,800
|
$13,171,004 | — | 30 Jun 2023 | |
| Clal Insurance Enterprises Holdings Ltd |
13F
|
Company |
1.5%
|
299,000
|
$12,014,000 | — | 30 Jun 2023 | |
| Woodline Partners LP |
13F
|
Company |
1.4%
|
279,701
|
$11,238,386 | — | 30 Jun 2023 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
1.4%
|
276,815
|
$11,122,427 | — | 30 Jun 2023 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
1.1%
|
214,003
|
$8,598,638 | — | 30 Jun 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1%
|
203,683
|
$8,183,983 | — | 30 Jun 2023 | |
| CITIGROUP INC |
13F
|
Company |
0.78%
|
152,847
|
$6,141,392 | — | 30 Jun 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.75%
|
147,785
|
$5,938,001 | — | 30 Jun 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.52%
|
101,638
|
$4,083,814 | — | 30 Jun 2023 | |
| WCM INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.48%
|
95,213
|
$3,802,807 | — | 30 Jun 2023 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.44%
|
86,727
|
$3,484,690 | — | 30 Jun 2023 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.42%
|
82,891
|
$3,330,560 | — | 30 Jun 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.37%
|
73,907
|
$2,969,583 | — | 30 Jun 2023 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.37%
|
71,992
|
$2,892,639 | — | 30 Jun 2023 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
0.36%
|
70,800
|
$2,844,744 | — | 30 Jun 2023 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.36%
|
70,256
|
$2,822,886 | — | 30 Jun 2023 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.35%
|
68,562
|
$2,754,819 | — | 30 Jun 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.35%
|
68,400
|
$2,748,000 | — | 30 Jun 2023 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.32%
|
62,650
|
$2,517,277 | — | 30 Jun 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.3%
|
58,766
|
$2,361,218 | — | 30 Jun 2023 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.29%
|
58,119
|
$2,335,221 | — | 30 Jun 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.29%
|
56,213
|
$2,258,638 | — | 30 Jun 2023 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.28%
|
55,341
|
$2,223,601 | — | 30 Jun 2023 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.26%
|
52,000
|
$2,089,360 | — | 30 Jun 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.26%
|
51,659
|
$2,075,659 | — | 30 Jun 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.25%
|
49,798
|
$2,000,884 | — | 30 Jun 2023 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.24%
|
47,661
|
$1,915,019 | — | 30 Jun 2023 | |
| Swiss National Bank |
13F
|
Company |
0.22%
|
43,500
|
$1,747,830 | — | 30 Jun 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.2%
|
39,896
|
$1,603,021 | — | 30 Jun 2023 | |
| BARCLAYS PLC |
13F
|
Company |
0.19%
|
38,393
|
$1,542,632 | — | 30 Jun 2023 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.17%
|
32,953
|
$1,324,051 | — | 30 Jun 2023 | |
| UBS Group AG |
13F
|
Company |
0.15%
|
29,716
|
$1,193,989 | — | 30 Jun 2023 |
Institutional Holders of Keros Therapeutics, Inc. - Common Stock, $0.0001 par value per share (KROS) as of Q3 2023
As of 30 Sep 2023,
Keros Therapeutics, Inc. - Common Stock, $0.0001 par value per share (KROS) was held by
106 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,915,590 shares.
The largest 10 holders included
FMR LLC, BlackRock Inc., ALKEON CAPITAL MANAGEMENT LLC, ORBIMED ADVISORS LLC, VANGUARD GROUP INC, BRAIDWELL LP, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, Candriam S.C.A., and Woodline Partners LP.
This page lists
106
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2023 vs Q2 2023 Across Filers
Q2 2023 holders
121
Q3 2023 holders
106
Holder diff
-15
| Investor | Q2 2023 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q2 2023 Value $ | Q3 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.